Cargando…

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

BACKGROUND: The prognostic value of body composition in cancer patients has been widely studied during the last decade. The main finding of these studies is that sarcopenia, or skeletal muscle depletion, assessed by CT imaging correlates with a reduced overall survival (OS). By contrast, the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charette, Nicolas, Vandeputte, Caroline, Ameye, Lieveke, Bogaert, Camille Van, Krygier, Jonathan, Guiot, Thomas, Deleporte, Amélie, Delaunoit, Thierry, Geboes, Karen, Van Laethem, Jean-Luc, Peeters, Marc, Demolin, Gauthier, Holbrechts, Stéphane, Flamen, Patrick, Paesmans, Marianne, Hendlisz, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371452/ https://www.ncbi.nlm.nih.gov/pubmed/30744591 http://dx.doi.org/10.1186/s12885-019-5319-8

Ejemplares similares

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
por: Woff, Erwin, et al.
Publicado: (2016)

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
por: Hendlisz, Alain, et al.
Publicado: (2015)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
por: Vandeputte, Caroline, et al.
Publicado: (2018)

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study
por: Deleporte, Amelie, et al.
Publicado: (2014)

Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study
por: Deleporte, Amélie, et al.
Publicado: (2021)

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
por: Hendlisz, Alain, et al.
Publicado: (2013)

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
por: Hendlisz, Alain, et al.
Publicado: (2015)

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU
por: Destrebecq, Virginie, et al.
Publicado: (2016)

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial
por: Rothé, Françoise, et al.
Publicado: (2019)

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Gombos, Andrea, et al.
Publicado: (2021)

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Gombos, Andrea, et al.
Publicado: (2022)

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
por: Camera, Silvia, et al.
Publicado: (2020)

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
por: Berghmans, Thierry, et al.
Publicado: (2015)

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
por: Berghmans, Thierry, et al.
Publicado: (2015)

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
por: Bouchart, Christelle, et al.
Publicado: (2023)

(90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2018)

Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer
por: Anciaux, Maelle, et al.
Publicado: (2020)

Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
por: Asmar, Antoine El, et al.
Publicado: (2020)

The INTER-ACT E-Health Supported Lifestyle Intervention Improves Postpartum Food Intake and Eating Behavior, but Not Physical Activity and Sedentary Behavior—A Randomized Controlled Trial
por: Bijlholt, Margriet, et al.
Publicado: (2021)

Evolution of Postpartum Weight and Body Composition after Excessive Gestational Weight Gain: The Role of Lifestyle Behaviors—Data from the INTER-ACT Control Group
por: Bijlholt, Margriet, et al.
Publicado: (2021)

Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
por: Roeyen, G., et al.
Publicado: (2022)

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
por: Demols, A, et al.
Publicado: (2006)

Latest developments and emerging treatment options in the management of stomach cancer
por: Delaunoit, Thierry
Publicado: (2011)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2016)

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma
por: Vouche, Michael, et al.
Publicado: (2017)

Mental Health during the Interpregnancy Period and the Association with Pre-Pregnancy Body Mass Index and Body Composition: Data from the INTER-ACT Randomized Controlled Trial
por: Van Uytsel, Hanne, et al.
Publicado: (2023)

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients
por: Gueuning, Candice, et al.
Publicado: (2022)

Effect of the INTER-ACT lifestyle intervention on maternal mental health during the first year after childbirth: A randomized controlled trial
por: Van Uytsel, Hanne, et al.
Publicado: (2023)

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
por: Elez, E, et al.
Publicado: (2016)

Clinico‐metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases
por: Bohlok, Ali, et al.
Publicado: (2021)

INTER-ACT: prevention of pregnancy complications through an e-health driven interpregnancy lifestyle intervention – study protocol of a multicentre randomised controlled trial
por: Bogaerts, Annick, et al.
Publicado: (2017)

Phase Angle and Bio-Impedance Values during the First Year after Delivery in Women with Previous Excessive Gestational Weight Gain: Innovative Data from the Belgian INTER-ACT Study
por: Bijlholt, Margriet, et al.
Publicado: (2021)

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
por: Bouchart, Christelle, et al.
Publicado: (2020)

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
por: Auclin, Edouard, et al.
Publicado: (2019)

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
por: Buvat, Irène, et al.
Publicado: (2012)

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
por: Maisonobe, Jacques-Antoine, et al.
Publicado: (2012)

Sex differences in fetal growth and immediate birth outcomes in a low-risk Caucasian population
por: Galjaard, Sander, et al.
Publicado: (2019)

The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases
por: Bohlok, Ali, et al.
Publicado: (2020)

Development and Field Evaluation of the INTER-ACT App, a Pregnancy and Interpregnancy Coaching App to Reduce Maternal Overweight and Obesity: Mixed Methods Design
por: Bogaerts, Annick, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96hb3rntt83pdhd9l7t0mdhgm9